期刊文献+

血清差异表达多肽谱用于人卵巢癌诊断的研究 被引量:4

Mass spectrometry analysis of sera peptides in diagnosis of ovarian cancer
下载PDF
导出
摘要 目的:建立卵巢癌患者血清差异表达多肽谱,并探讨其潜在诊断价值。方法:应用磁珠富集多肽结合基质辅助激光解吸电离飞行时间质谱(matrix-assisted laser desorption/ionization time-of-flight mass spectrometry,MALDI-TOF-MS)检测方法,筛选上皮性卵巢癌组和健康对照组差异表达多肽峰,利用ClinProTools软件比较两组血清多肽表达差异并建立差异表达多肽谱及早期诊断模型。结果:在卵巢癌组血清中,m/z 2 662.02、2 653.68、5 859.21、5 901.69、5 937.06表达显著上调;m/z 1 857.82、2 074.28、2 856.33表达显著下调。差异表达图谱建立的诊断模型预测早期卵巢癌的准确率达到81.8%(9/11),利用9例宫颈癌血清验证均为阴性,特异性达100%(0/9)。结论:磁珠富集-质谱结合ClinProTools生物信息学分析技术,有望成为新的人卵巢癌辅助诊断技术。 Objective:To establish the expression profiles of peptides in sera of ovarian cancer and explore the early-diagnosis value of expression profiles of peptides in ovarian cancer. Methods:Magnetic binding-weak cation exchange beads (MB-WCX) and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) analysis were used to detect expression files of peptides. The early-diagnosis pattern was established by differential peptides peaks using the ClinProTool data analysis program. Results:In the mass range from 1 000 to 15 000 Da,8 peaks with clear differences in amplitude between the patients and health controls were detected,5 peaks with mass charge ratio (m/z) of 2 662.02, 2 653.68,5 859.21,5 901,69 and 5 937.06 were up-regulated notably,and 3 peaks with m/z of 1 857.82,2 074.28 and 2 856.33 were markedly down-regulated in patients with ovarian cancer. In specimens of early-stage ovarian cancer,the accuracy of characteristic proteomic patterns detection could be 81.8% (9/11 ), and the specificity showed 100%. Conclusion:MB-WCX separation coupled with MALDI-TOF-MS and ClinProTools analysis could be a desired method to find bio-markers in ovarian cancer,and could have a potential value in the early diagnosis of ovarian cancer.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2012年第7期1029-1032,共4页 Journal of Nanjing Medical University(Natural Sciences)
基金 江苏省自然科学基金(BK2011164) 江苏省卫生厅科研项目(X201110)
关键词 卵巢癌 磁珠富集 时间飞行质谱 血清多肽 ovarian cancer magnetic binding matrix-assisted laser desorption/ionization time-of-flight mass spectrometry serum
  • 相关文献

参考文献14

  • 1董丽华,孙玮,傅士龙,韩素萍.人正常卵巢组织中成纤维细胞的培养[J].南京医科大学学报(自然科学版),2011,31(10):1527-1532. 被引量:3
  • 2王静,张小为,葛晓慧,郭红燕,熊光武,韩劲松,张璐芳.晚期卵巢癌的血浆蛋白质组学模型用于早期卵巢癌诊断的初步研究[J].中国妇产科临床杂志,2008,9(2):124-127. 被引量:3
  • 3彭小宁,彭司华,曾小敏.卵巢癌早期诊断方法的研究进展[J].国际病理科学与临床杂志,2007,27(6):489-492. 被引量:3
  • 4乐杰主编..妇产科学 第6版[M].北京:人民卫生出版社,2004:476.
  • 5Jianyang Pan,Qiao Wang,Qing Shao,Yiyu Cheng,Haibin Qu.Development and Validation of a Column-Switching LC–ESI–MS Assay for Determination of Huperzine?A in Rat Plasma and Cerebrospinal Fluid[J].Chromatographia (-).2009(5-6) 被引量:1
  • 6Hays JL,Kim G,Giuroiu I,et al.Proteomics and ovarian cancer:integrating proteomics information into clinical care[].J Proteomics.2010 被引量:1
  • 7Huang Y Z,Yang G J,Kurian Det al.Proteomic patternsas biomarkers for the early detection of schistosomiasisjaponica in a rabbit model[].Int J Mass Spectron.2011 被引量:1
  • 8Terry Nguyen-Khuong,Anna Fitzgerald,Zhejun Zhao,et al.Improvements for the visualization of low-molecular weight protein and peptides of human tears using MALDI[].Proteomics.2008 被引量:1
  • 9Villanueva J,Philip J,Entenberg D,et al.Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry[].Analytical Biochemistry.2004 被引量:1
  • 10Petricoin EF,Ardekani AM,Hitt BA,et al.Use of proteomic patterns in serum to identify ovarian cancer[].The Lancet.2002 被引量:1

二级参考文献46

  • 1[1]Whitehouse C,Solomon E.Current status of the molecular characterization of the ovariancancer antigen CA125 and implications for its use in clinical screening.Gynecol Oncol,2003,88:152-157. 被引量:1
  • 2[2]Brazert J,Piet ryga M,Szablonski W,et al.Diagnostic value of the morphological ultrasound scoresystem and the serum concentration of CA125 in the diagnosis of malignant ovarian cancer.Ginekol Pol,2003,74:1542-1547. 被引量:1
  • 3[3]Conrads TP,Hood BL,Issaq HJ,et al.Proteomic patterns as a diagnostic tool for early-stage cancer:a review of it s progress to a clinically relevant tool.Mol Diagn,2004,8:77-83. 被引量:1
  • 4[4]Petricoin EF,Ardekani AM,Hitt BA,et al.Use of proteomic patterns in serum to identify ovarian cancer.Lancet,2002,359:572-577. 被引量:1
  • 5[5]Rai AJ,Zhang Z,Rosenzweig J,et al.Proteomic approaches to tumor marker discovery.Arch Pathol Lab Med,2002,126:1518-1526. 被引量:1
  • 6[6]Ye B,Cramer DW,Skates SJ,et al.Haptoglobin-alpha subunit as potential serum biomarker inovarian cancer:identification and characterization using proteomic profiling and mass spectrometry.Clin Cancer Res,2003,9:2904-2911. 被引量:1
  • 7[7]Moshkovskii SA,Serebryakova MV.Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1.Proteomics,2005,5:3790-3797. 被引量:1
  • 8[8]Rai AJ,Gelfand CA,Haywood BC,et al.HUPO Plasma Proteome Project specimen collection and handling:towards the standardization of parameters for plasma proteome samples.Proteomics,2005,5:3262-3277. 被引量:1
  • 9[9]Lee Y,Lee C.Classification of multiple cancer types by multicategory support vector machines using gene expression data.Bioinformatics,2003,13:1132-1139. 被引量:1
  • 10[10]Martijn D,Roel JV,Ritsert CJ.SELDI-TOF mass spectra:A view on sources of variation.J Chroma B,2007,847:12-23. 被引量:1

共引文献6

同被引文献34

  • 1Ketterlinus R,Hsieh SY,Teng SH,et al. Fishing for biomarkers:analyzing mass spectrometry data with the new C|inProTools software [ J ]. Biotechniques, 2005, Sup- pl: 37-40. 被引量:1
  • 2Clerc O,Prod'hom G,Vogne C,et al. Impact of matrix-as- sisted laser desorption ionization time-of-flight mass spec- trometry on the clinical management of patients with Gram-negative bacteremia: a prospective observational study[J]. Clin Infect Dis,2013,56(8) : 1101-1107. 被引量:1
  • 3Kok J,Chen SC,Dwyer DE,et al. Current status of matrix- assisted laser desorption ionisation-time of flight massspectrometry in the clinical microbiology laboratory [J]. Pathology, 2013,45 ( 1 ) : 4-17. 被引量:1
  • 4Shah FD,Begum R,Vajaria BN,et al. A review on sali- vary genomics and proteomics biomarkers in oral cancer [J]. Indian J Clin Bioehem, 2011,26(4): 326-334. 被引量:1
  • 5Zurbig P,Jahn H. Use of proteomic methods in the analy- sis of human body fluids in Alzheimer research[J]. Elec- trophoresis, 2012,33(24) : 3617-3630. 被引量:1
  • 6Tang W,Shi YQ,Zou JJ,et al. Serum biomarker of diabetic peripheral neuropathy indentified by differential pro- teomics [J]. Front Biosci(Landmark Ed), 201 I, 16 : 2671 - 2681. 被引量:1
  • 7Savino R, Paduano S, Preiano M, et al. The proteomics big challenge for biomarkers and new drug-targets discovery [J]. Int J Mol Sci,2012,13(11) : 13926-13948. 被引量:1
  • 8Huang Z, Yang GY, Kurian D, et al. Proteomic patterns as biomarkers for the early detection of Schistosomiasis japonica in a rabbit mode/ [J]. Int J Mass Spectrometry, 2011. 299 (2"), 191-195. 被引量:1
  • 9Gryseels B,Polman K, Cierinx J,et al. Human schistoso- miasis [ J ]. Lancet, 2006,368 (9541 ) : 1106-1118. 被引量:1
  • 10Li-rong ZHU,Wen-ying ZHANG,Li YU,Yan-hua ZHENG,Jun HU,Qin-ping LIAO.Proteiomic patterns for endometrial cancer using SELDI-TOF-MS[J].Journal of Zhejiang University-Science B(Biomedicine & Biotechnology),2008,9(4):286-290. 被引量:7

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部